This episode is part of our Expert Interview Series. In each episode of this series, we’ll interview industry professionals for their perspective on the evolving specialty pharmacy market.
On the heels of the 21st Century Cures Act being passed by the House of Representatives late last year, special guest Marie Anderson, Senior Vice-President, Operation/Payor Strategy at CSI Specialty Group, joins host Suzette DiMascio, CHE, CMCE, CPC, for an in-depth discussion on how the new bill will impact specialty pharmacy, patients, and the pharmaceutical industry as a whole.
Tune in to Discover:
- The promising funding provisions of the bill and the potential implications it has for specialty pharmacy
- How the 21st Century Cures Act will affect the speed of drugs getting to market
- What the bill’s additional fund allocations to the FDA mean for the pharmaceutical world
- How patient realities and experiences played a key role in forming the bill and the impact it will have on improving the lives of patients with rare and orphan diseases
- The opportunities the 21st Century Cures Act will provide for technological advancements, biomedical research, and science as a whole
About Marie Anderson
Marie Anderson is an experienced executive with an extensive background in a broad scope of health care dimensions. She has held leadership roles in Specialty Pharmacy, PBM, Home Health, Contracting, Operations, Product Development, 340b, Community Health and Billing and Reimbursement.
Marie is a subject matter expert in all things Payor, including Medicare and Medicaid and has worked to develop innovations in widely recognized managed care programs. Marie’s initial industry expertise positioned her working directly with major payors in member services and claims for Prudential and Cigna. She then shifted to the provider world and was part of the start up management team at Accredo Health Group.
Marie has led Product Development at Express Scripts and was an executive at Presbyterian Medical Services, serving the underserved in Community Health Care in New Mexico.
She was also responsible for development of Specialty operations and processes at Prime, building Specialty Rx from the ground up. Under her direction, in just one year, Prime’s Specialty Pharmacy grew to over $1 Billion dollars annually, with an average DSO
Marie has a Bachelor of Science in Business Administration and is a Certified Six Sigma Process Improvement Manager.
About CSI Specialty Group
CSI Specialty Group is a globally recognized; WBE Certified Leadership Consulting Firm dedicated to providing solutions that continually elevate the specialty pharmacy industry. By providing inventive specialty pharmacy consulting, workforce planning and talent acquisition solutions, CSI uniquely tailors its service offerings to help clients drive sustainable, accelerated growth. As the provider of the industry’s first, dedicated podcast for specialty pharmacy, CSI is at the forefront of pioneering innovative concepts to meet the changing needs of specialty pharmacy, home infusion, mail order/PBM, health systems and pharma/biotech clients across the USA and throughout Europe.
Senior Vice-President, Operation/Payor Strategy
CSI Specialty Group
400 Lexington Green Lane
Sanford, FL 32771